Furthermore, findings from a longitudinal study of 145 early-stage breast cancer patients suggested that carriers of BDNF Met allele could protect cancer patients against post chemotherapy cognitive impairment [4]. The gene discussed is BDNF; the disease is Cognitive impairment.